4//SEC Filing
Spaventa Andrew 4
Accession 0000950170-25-021402
CIK 0001850906other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:00 PM ET
Size
13.5 KB
Accession
0000950170-25-021402
Insider Transaction Report
Form 4
Spaventa Andrew
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-12+1,907→ 2,232 total - Sale
Common Stock
2025-02-14$19.89/sh−800$15,912→ 1,432 total - Exercise/Conversion
Restricted Stock Units
2025-02-12−1,907→ 22,873 total→ Common Stock (1,907 underlying) - Gift
Common Stock
2025-02-14−1,107→ 325 total - Gift
Common Stock
2025-02-14+1,107→ 142,900 total(indirect: By Trust)
Holdings
- 85(indirect: By LLC)
Common Stock
Footnotes (7)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted RSUs.
- [F3]Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.88 to $19.91, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]Immediately upon settlement of the vested RSUs, and following the withholding described above, the Reporting Person transferred the shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
- [F5]The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- [F6]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F7]The RSUs vest in 16 equal quarterly installments over four years measured from February 12, 2024.
Documents
Issuer
Singular Genomics Systems, Inc.
CIK 0001850906
Entity typeother
Related Parties
1- filerCIK 0001859701
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:00 PM ET
- Size
- 13.5 KB